Ciro Florio

Naples, 80131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project.

Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 19, 2020

One year experience with erenumab: real-life data in 30 consecutive patients.

One year experience with erenumab: real-life data in 30 consecutive patients.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: August 27, 2020

Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis.

Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis.

Journal: Brain : a journal of neurology

Published: February 15, 2020

Remission of early persistent cladribine-induced neutropenia after filgrastim therapy in a patient with Relapsing - Remitting Multiple Sclerosis.

Remission of early persistent cladribine-induced neutropenia after filgrastim therapy in a patient with Relapsing - Remitting Multiple Sclerosis.

Journal: Multiple sclerosis and related disorders

Published: January 31, 2020

GABAA receptor autoimmunity after alemtuzumab treatment for multiple sclerosis.

GABAA receptor autoimmunity after alemtuzumab treatment for multiple sclerosis.

Journal: Neurology

Published: December 13, 2019

Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study.

Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study.

Journal: Multiple sclerosis and related disorders

Published: May 09, 2019

Early neutropenia with thrombocytopenia following alemtuzumab treatment for multiple sclerosis: case report and review of literature.

Early neutropenia with thrombocytopenia following alemtuzumab treatment for multiple sclerosis: case report and review of literature.

Journal: Clinical neurology and neurosurgery

Published: May 18, 2018

THC/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study.

THC/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: May 03, 2017

Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration.

Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration.

Journal: Metabolism: clinical and experimental

Published: April 24, 2017

Less Frequent and Less Severe Flu-Like Syndrome in Interferon Beta-1a Treated Multiple Sclerosis Patients with at Least One Allele Bearing the G>C Polymorphism at Position -174 of the IL-6 Promoter Gene.

Less Frequent and Less Severe Flu-Like Syndrome in Interferon Beta-1a Treated Multiple Sclerosis Patients with at Least One Allele Bearing the G>C Polymorphism at Position -174 of the IL-6 Promoter Gene.

Journal: PloS one

Published: June 05, 2015

No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study).

No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study).

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: February 25, 2015

Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate.

Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate.

Journal: Metabolism: clinical and experimental

Published: February 11, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026